Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,604.50
Bid: 1,604.00
Ask: 1,604.50
Change: -5.50 (-0.34%)
Spread: 0.50 (0.031%)
Open: 1,611.50
High: 1,615.50
Low: 1,599.50
Prev. Close: 1,610.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks end flat between Asia worries, British re-opening cheer

Mon, 17th May 2021 09:43

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Asia restrictions, China data weigh

* Kinnevik jumps to top of STOXX 600

* Spain's Telefonica gains as it seeks buyers for delivery
arm

* Sanofi, GSK gain as COVID-19 vaccine shows immune response
(Updates with market close)

By Shashank Nayar and Sruthi Shankar

May 17 (Reuters) - European stocks ended flat on Monday as
underwhelming Chinese data and caution over the spread of a
COVID-19 variant outweighed optimism on the reopening of the
British economy, while Sweden's Kinnevik surged and was the top
performer.

The pan-European STOXX 600 index ended flat with
travel and leisure stocks being the top losers, down
2.3%, while telecommunication stocks jumped the most,
led by gains in Spanish telecom firm Telefonica

Dampening sentiment was data showing that China's factories
slowed their output growth in April and retail sales
significantly missed expectations as officials warned of new
problems affecting the economic recovery.

Meanwhile, fresh restrictions across Asia following a new
wave of COVID-19 cases and concerns over the spread of a
fast-spreading coronavirus variant first identified in India
overshadowed optimism on UK's economic reopening.

"Airlines are on the back foot once again today, with
optimism over the reopening of international travel proving
short-lived given concerns over the growth of the Indian COVID
variant," said Joshua Mahony, senior market analyst at IG.

"Unfortunately, the risks posed by this latest strain also
raise questions around those same businesses that have just
found reprieve from lockdown restrictions, with pub and
restaurant chains all on the back foot despite the resumption of
indoor dining," added Mahony.

Britain's domestically focused mid-cap index dropped
0.6%, with restaurant and pub operator SSP Group and
airlines Easyjet and Wizz Air Holdings being
the top drags.

Irish airline Ryanair fell 2.8% after reporting a
record annual after-tax loss, as it said there were signs the
recovery had begun.

European stocks have performed well so far and surged to
all-time highs this month, with the STOXX 600 up nearly 11% so
far this year as economic recovery prospects and strong earnings
drew buyers of equities.

The European Union has agreed to a partial truce with the
United States in a dispute over metal tariffs imposed by former
President Donald Trump and to start discussions on global
overcapacity and China's "trade-distorting" policies.

Mining stocks gained 0.9%.

In corporate news, Sweden's Kinnevik jumped 8.5%
to the top of the STOXX 600 index after the company transferred
its stake in online fashion retailer Zalando to
shareholders.

Spanish telecoms group Telefonica gained 3.5% as it
is seeking buyers for its logistics and express-delivery unit
Zeleris, a source familiar with the offer said on Monday, amid a
months-long boom in the business as COVID-19 pushes people to
shop online.

Drugmakers Sanofi and GlaxoSmithKline
jumped 1% and 0.7% respectively after their experimental
COVID-19 vaccine showed a robust immune response in early-stage
clinical trial results, enabling them to move to a late-stage
study.
(Reporting by Sruthi Shankar and Shashank Nayar in Bengaluru;
Editing by Subhranshu Sahu and Dan Grebler)

More News
3 Jun 2024 17:19

Pharma, energy stocks drag London's FTSE 100; ECB rate cut hopes cap losses

FTSE 100 down 0.2%, FTSE 250 up 0.8%

*

Read more
3 Jun 2024 17:00

LONDON MARKET CLOSE: FTSE 100 down amid shaky start in New York

(Alliance News) - The FTSE 100 in London closed lower on Monday, marking a mixed start to June, with GSK firmly at the bottom of the index.

Read more
3 Jun 2024 14:01

GSK immunotherapy bowel cancer drug works for 100% of patients

(Alliance News) - An immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it was effective in 100% of cases.

Read more
3 Jun 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 up, while Labour commits to defence

(Alliance News) - Stock prices in London were up at midday, after data from S&P Global signalled a return to growth for the UK manufacturing sector.

Read more
3 Jun 2024 09:08

TOP NEWS: GSK vows to appeal adverse Delaware court ruling on Zantac

(Alliance News) - GSK PLC on Monday said it will appeal a US court ruling that it should face jury trials relating to cases concerning the heartburn drug, Zantac.

Read more
3 Jun 2024 08:37

LONDON MARKET OPEN: Stocks up amid slew of manufacturing PMIs

(Alliance News) - Stock prices in London opened higher on Monday, ahead of local purchasing managers index data, and comparative prints from several other major global economies.

Read more
3 Jun 2024 08:00

LONDON BRIEFING: FTSE 100 seen up; GSK defends ranitidine cancer claim

(Alliance News) - Stocks in London are set to open higher on Monday, ahead of a data-heavy week, kicked off by a slew of manufacturing purchasing managers' index readings.

Read more
3 Jun 2024 07:30

GSK to appeal Delaware ruling on jury trials in Zantac cancer cases

(Sharecast News) - GSK shares were down almost 10% on Monday after a US court ruled that jury trials could hear expert witnesses in 70,000 cases brought by cancer sufferers claiming its Zantac heartburn drug caused their condition.

Read more
1 Jun 2024 21:35

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
1 Jun 2024 21:07

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
31 May 2024 17:45

US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label

May 31 (Reuters) - The U.S. Food and Drug Administration approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
31 May 2024 16:01

US FDA approves Moderna's RSV vaccine, its second marketed product

May 31 (Reuters) - The U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
30 May 2024 20:56

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 30 (Reuters) - A third U.S. dairy worker tested positive for bird flu after exposure to infected cows, and was the first to suffer respiratory symptoms, U.S. officials said on Thursday in the latest expansion of the outbreak. Bird flu has been found in dairy cattle in nine states. This second case in a Michigan dairy worker was found through increased testing of people and cows in the state following the April 1 identification of a case in a Texas farm worker. Here's what you need to know about the outbreak.

WHY IS H5N1 OR BIRD FLU A CONCERN?

Read more
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.